The Radical Power of Scraping Paperwork

When state regulators decide to get out of the way, private initiative moves with remarkable speed. For years, Australian bureaucracy wrapped the distribution of the abortion medication MS-2 Step in thick layers of administrative red tape, insisting that general practitioners complete special registration and that pharmacies jump through dedicated hoops merely to stock two routine pills. In 2023, the Therapeutic Goods Administration finally abandoned these artificial barriers. The outcome, as detailed in a La Trobe University study published in JAMA Network Open, proves a familiar rule: red tape rarely protects patients; it mostly just suffocates supply.

The empirical evidence is striking. By mid-2025, the number of Australian pharmacies stocking the two-drug regimen of mifepristone and misoprostol rose from 2,228 to 4,107—a 49 percent surge in just two years. Geographic coverage expanded from 915 to 1,292 postcodes. The gains were most pronounced precisely where centralized state planning routinely fails to deliver: in regional and remote areas. Regional coverage grew from 23 to 35 percent of postcodes, while the share of stocking pharmacies in remote communities nearly doubled, climbing from 12.5 to 22 percent.

The mechanism behind this expansion was notably unglamorous: the simple abolition of useless paperwork. Qualified nurse practitioners and endorsed midwives gained prescribing authority, while family doctors were suddenly trusted to practice medicine without requiring special government certification for this specific prescription. Pharmacies were freed from mandatory registration schemes. Without federal regulators breathing down their necks, local healthcare providers and pharmacists simply coordinated to meet existing demand.

This sudden flourishing of availability highlights the quiet burden that bureaucratic overreach routinely imposes on healthcare markets. When authorities treat standard pharmaceutical care as an exceptional case requiring specialized permits, they create invisible overhead for doctors and structural bottlenecks for patients. The transition towards medical rather than surgical intervention—a trend already well established across Europe, where medication accounts for over 90 percent of terminations—does not require grand state schemes or subsidised infrastructure. It merely requires regulators to stop treating administrative complexity as a substitute for safety. One wonders how many other routine services remain needlessly constrained simply because a government department has yet to scrap a few legacy forms.

Written by Thorben Thiede thorben.thiede@alpineweekly.com